NYSE:LLY - Eli Lilly And Co Stock Price, News & Analysis

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co announced a quarterly dividend on Tuesday, June 18th. Stockholders of record on Thursday, August 15th will be paid a dividend of $0.645 per share on Tuesday, September 10th. This represents a $2.58 annualized dividend and a dividend yield of 2.32%. The ex-dividend date is Wednesday, August 14th. View Eli Lilly And Co's Dividend History.

Eli Lilly And Co (NYSE:LLY) issued its earnings results on Tuesday, July, 30th. The company reported $1.50 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.45 by $0.05. The company earned $5.64 billion during the quarter, compared to analyst estimates of $5.59 billion. Eli Lilly And Co had a return on equity of 70.86% and a net margin of 33.76%. The firm's revenue was up .9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.48 earnings per share. View Eli Lilly And Co's Earnings History.

Eli Lilly And Co is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Wednesday, October 23rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Eli Lilly And Co issued an update on its FY19 earnings guidance on Tuesday, July, 30th. The company provided EPS guidance of $5.67-5.77 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.66. The company issued revenue guidance of $22-22.5 billion, compared to the consensus revenue estimate of $22.18 billion.

16 Wall Street analysts have issued 12-month target prices for Eli Lilly And Co's shares. Their forecasts range from $74.51 to $143.00. On average, they anticipate Eli Lilly And Co's stock price to reach $123.1227 in the next year. This suggests a possible upside of 10.9% from the stock's current price. View Analyst Price Targets for Eli Lilly And Co.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 7 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eli Lilly And Co.

Media headlines about LLY stock have been trending positive this week, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Eli Lilly And Co earned a news sentiment score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for Eli Lilly And Co.

Eli Lilly And Co saw a decrease in short interest during the month of July. As of July 31st, there was short interest totalling 11,459,200 shares, a decrease of 6.2% from the June 30th total of 12,215,500 shares. Based on an average daily volume of 4,080,000 shares, the short-interest ratio is currently 2.8 days. Approximately 1.3% of the company's stock are sold short. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Novartis (NVS), Pfizer (PFE), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), AstraZeneca (AZN), Sanofi (SNY), GlaxoSmithKline (GSK), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Bayer (BAYRY), Celgene (CELG) and Zoetis (ZTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Intel (INTC), AT&T (T), General Electric (GE), Exxon Mobil (XOM), Cisco Systems (CSCO), Gilead Sciences (GILD) and Bank of America (BAC).

Eli Lilly And Co's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.37%), BlackRock Inc. (6.42%), Primecap Management Co. CA (4.47%), Northern Trust Corp (1.15%), Price T Rowe Associates Inc. MD (0.89%) and Bank of New York Mellon Corp (0.82%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Daniel Skovronsky, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View Institutional Ownership Trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Janus Henderson Group PLC, Jennison Associates LLC, Jennison Associates LLC, Schroder Investment Management Group, Morgan Stanley, Nomura Holdings Inc. and Investec Asset Management LTD. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View Insider Buying and Selling for Eli Lilly And Co.

LLY stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Renaissance Technologies LLC, Grantham Mayo Van Otterloo & Co. LLC, AQR Capital Management LLC, BlackRock Inc., Thoroughbred Financial Services LLC, Amundi Pioneer Asset Management Inc. and Vanguard Group Inc.. Company insiders that have bought Eli Lilly And Co stock in the last two years include Daniel Skovronsky, Jackson P Tai and Joshua L Smiley. View Insider Buying and Selling for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $111.01.

Eli Lilly And Co has a market capitalization of $107.17 billion and generates $24.56 billion in revenue each year. The company earns $3.23 billion in net income (profit) each year or $5.55 on an earnings per share basis. Eli Lilly And Co employs 38,680 workers across the globe.View Additional Information About Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]